BLUEJET.NS

Blue Jet Healthcare Limited

NSEHealthcare

₹557.00

▼ -1.97%-₹11.20 today

₹0.00₹0.00

Ask Warren

Open

₹0.00

Prev close

₹568.20

Day range

₹0 – ₹0

52W range

₹325 – ₹1,027.8

Volume

4.5L

Avg vol (20D)

9.3L

Mkt cap

₹9,644.68Cr

P/E TTM

39.0×

Trade Blue Jet Healthcare Limited with Artha

Company Metrics

Revenue (ttm)₹947.32 Cr

Net Income (ttm)₹0.00

Shares Out17.35 Cr

EPS (ttm)

Forward PE

Dividend

Ex-Dividend DateInvalid Date

Trading Metrics

Beta0.77

About BLUEJET.NS

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norway, France, the United States, Italy, Sweden, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India.

IndustryBiotechnology

SectorHealthcare

Employees0

Stock ExchangeNSE

Ticker SymbolBLUEJET.NS

Websitehttps://www.bluejethealthcare.com

BLUEJET.NS · NSE

Financial Performance

In 2026, Blue Jet Healthcare Limited's revenue was ₹947.32 Cr, an decrease of +31.10% compared to the previous year. Earnings were ₹0.00, an decrease of +41.50%.

Revenue (2026)

₹947.32 Cr

↘-31.10% YoY

Earnings (2026)

₹0.00

↘-41.50% YoY

Year-over-Year Growth

Revenue

-31.10%

Earnings

-41.50%

News

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades

Create free account